Tobacco Induced Diseases is a leading open-access journal published by EUROPEAN PUBLISHING, dedicated to advancing research in the critical fields of tobacco-related health issues, epidemiology, and public policy. With an ISSN of 1617-9625, this esteemed journal has been nurturing academic discourse since its inception in 2002, situated in the picturesque backdrop of Heraklion, Crete. Recognized for its rigorous publication standards and impactful contributions, the journal proudly holds a Q1 ranking in Health (Social Science) and consistently ranks within the top quarters for both Medicine (Miscellaneous) and Public Health, Environmental, and Occupational Health. With impressive Scopus rankings, including #67 in Health and #99 in Medicine, it serves as an essential platform for researchers, professionals, and students aiming to understand and address the pressing challenges associated with tobacco use and its long-term health implications. As the journal converges its research coverage from 2009 to 2024, it invites contributions that span multidisciplinary perspectives and innovative approaches to tackling tobacco-induced diseases.

Translational Behavioral Medicine, published by Oxford University Press, is a premier academic journal dedicated to advancing the field of behavioral medicine through high-quality research and innovative methodologies. With an ISSN of 1869-6716 and an impressive E-ISSN of 1613-9860, the journal serves as a vital platform for disseminating findings that bridge the gap between laboratory research and clinical practice. Ranking in the prestigious Q1 category for both Applied Psychology and Behavioral Neuroscience, it holds a prominent position within the academic community, as reflected by its Scopus rankings—17th out of 88 in Behavioral Neuroscience and 57th out of 249 in Applied Psychology. Although currently non-Open Access, the journal provides a wealth of knowledge for researchers, professionals, and students interested in the interplay of behavioral science and health. With converged years from 2011 to 2024, Translational Behavioral Medicine continues to be an essential resource for those committed to enhancing our understanding of how behavioral factors contribute to health and illness.

Suchttherapie, an esteemed journal published by GEORG THIEME VERLAG KG, serves as a critical platform within the fields of Applied Psychology and Psychiatry and Mental Health. Established in 2000 and continuing through 2024, this journal is committed to advancing the understanding and treatment of addiction and related psychological issues. Although it currently stands in the Q4 Quartile ranking and is categorized as low percentile in both Scopus Ranks and impact metrics, its significance lies in its dedication to disseminating cutting-edge research and clinical findings that contribute to the evolving landscape of therapeutic practices. Published in Germany, the journal facilitates unlimited access to the vital discourse surrounding mental health and addiction treatment, making it a valuable resource for researchers, professionals, and students alike seeking to enhance their knowledge and skills in this important area of study. As the field continues to grow, Suchttherapie plays a pivotal role in bridging practice with academic rigor, ensuring that readers remain informed on the latest methodologies and insights.

ADDICTION, published by Wiley, is a highly regarded academic journal that serves the vibrant fields of Medicine and Psychiatry and Mental Health. With an impressive impact factor reflective of its significance—ranking in the top 8% and 7.5% of its categories respectively—this journal is esteemed for its rigorous peer-reviewed research which spans a wide array of topics related to addiction, including pharmacology, prevention, and treatment modalities. Since its inception in 1993, ADDICTION has continually provided a platform for innovative research, shaping the discourse and influencing clinical practices worldwide. This journal, based in the United Kingdom at a prestigious location in Hoboken, NJ, stands as a beacon for researchers, practitioners, and students alike, committed to advancing understanding and strategies to combat addiction-related challenges. Although it is not an Open Access publication, the journal's contribution to the field remains invaluable, ensuring that cutting-edge findings are disseminated widely among professionals dedicated to improving mental health outcomes.

Tobacco Use Insights is a leading open-access journal dedicated to advancing the understanding of tobacco use and its implications for public health. Published by SAGE Publications Ltd, this journal provides a platform for innovative research, critical reviews, and practice-oriented articles that span the diverse dimensions of tobacco consumption, cessation, policy impacts, and prevention strategies. With a commitment to facilitating knowledge dissemination since its inception in 2009, Tobacco Use Insights serves an international audience of researchers, health professionals, and students who are engaged in the ongoing fight against tobacco-related health issues. The journal is indexed and accessible across multiple databases, reinforcing its influence within the field and ensuring wide visibility for its contributors. The journal's insightful contributions play an essential role in shaping effective tobacco control policies and fostering healthier communities globally.

Tobacco Prevention & Cessation is a vital open-access journal published by EUROPEAN PUBLISHING, dedicated to advancing knowledge in the fields of public health and tobacco control. Established in 2015, this journal provides a platform for the dissemination of high-quality research aimed at reducing tobacco use and improving cessation strategies worldwide. With an impressive impact across various categories, including a Q1 ranking in Health Professions, the journal is integral to the global health community, highlighting critical issues related to tobacco prevention and cessation practices. Researchers and practitioners can benefit from access to cutting-edge studies designed to inform policies and practices, making this journal an essential resource for those committed to combating tobacco-related health challenges. Operating under an open-access model, Tobacco Prevention & Cessation ensures that impactful research is available to all, furthering its mission of fostering public health education and awareness.

Economics & Human Biology, published by Elsevier, is a prestigious journal that serves as an interdisciplinary platform at the intersection of economics and health sciences. With ISSN 1570-677X and E-ISSN 1873-6130, this journal analyzes the implications of economic factors on human health and biological outcomes. As a recognized leader in its field, it has earned a remarkable Q1 ranking in both the Economics, Econometrics and Finance (miscellaneous) and Health (social science) categories for 2023, reflecting its significant impact within the academic community, as evidenced by its Scopus rank of 88 out of 371 and a 76th percentile ranking in Health social sciences. Highlighting key issues such as health disparities, economic policy impacts on health, and the biological determinants of economic behavior, the journal encourages innovative research that bridges these critical domains. Researchers, professionals, and students seeking to contribute to or stay informed on emerging trends in health economics will find this journal an invaluable resource. Explore the latest findings and engage with a community dedicated to advancing our understanding of the interplay between economics and human biology.

Journal of Substance Use & Addiction Treatment is a premier scholarly publication dedicated to advancing the understanding and treatment of substance use disorders and addictive behaviors. Published by Elsevier Science Inc, this journal serves as a vital platform for researchers, clinicians, and students in the fields of psychology, psychiatry, public health, and addiction studies. With its commitment to Open Access, the journal facilitates wide dissemination of cutting-edge research, enabling practitioners and policymakers to access critical findings that inform treatment approaches and public health strategies. As an essential resource in addiction treatment and research, the Journal of Substance Use & Addiction Treatment aims to foster interdisciplinary collaboration and innovation, ultimately improving outcomes for individuals affected by addiction.

TOBACCO CONTROL is a leading journal published by the BMJ Publishing Group, dedicated to advancing the field of public health, especially concerning tobacco usage and its multifaceted impacts on society. With an ISSN of 0964-4563 and E-ISSN of 1468-3318, this journal offers unparalleled insights into tobacco control policy, epidemiology, and behavioral studies, fostering a platform for research that can significantly influence public health strategies worldwide. Recognized with a Q1 ranking in the fields of Health (social science) and Public Health, Environmental and Occupational Health for 2023, TOBACCO CONTROL holds a prestigious position among the top journals in its domain, with an impressive Scopus rank of #17 out of 371 in Health (social science) and #48 out of 665 in Public Health. Through its commitment to rigorous peer review and high-quality research articles, the journal aims to disseminate knowledge that can combat the tobacco epidemic, ultimately contributing to improved health outcomes. Although not open access, the journal's dedicated focus on illuminating effective tobacco control measures makes it an essential resource for researchers, policymakers, and health professionals alike.

Drug and Alcohol Dependence is a premier journal published by Elsevier Ireland Ltd, dedicated to the rigorous exploration and analysis of substance use disorders, including drug and alcohol dependencies. With its established history since 1975 and a remarkable convergence of research extending to 2024, the journal holds a prestigious position within the academic community, evidenced by its Q1 ranking in multiple categories, including Pharmacology, Psychiatry and Mental Health, and Toxicology for 2023. It ranks impressively among its peers, underscored by Scopus rankings of #46, #99, and #27 in key fields related to medical pharmacology and toxicology. As a non-open access title, it caters to a global readership of researchers, professionals, and students, providing them with peer-reviewed insights into critical developments and innovative methodologies in the field. The journal’s commitment to advancing knowledge and understanding of drug and alcohol dependence is essential for addressing the global challenges posed by substance use, making it a valuable resource for all stakeholders in public health and clinical practice.